Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Melda Sariman"'
Publikováno v:
Genetics & Applications, Vol 7, Iss 1 (2023)
Lung cancer is one of the most common cancers in the world and a leading cause of death. Cancer stem cells (CSCs) are the cells responsible for tumor initiation. CSCs features include self-renewal capacity, differentiation, high invasion-migration, a
Externí odkaz:
https://doaj.org/article/f5c3efdc8ad045189277305ac13418c2
Autor:
Melda Sariman, Burcu Salman Yaylaz, Mesut Ayer, Sema Sirma Ekmekci, Ilknur Suer, Kıvanc Cefle, Sukru Palanduz, Sukru Ozturk, Meliha Nalcaci, Neslihan Abaci
Purpose: Plasma Cell Dyscrasias are a heterogeneous group of hematological diseases. The candidate ten genes identified from our transcriptome data are highly valuable and specific. Methods: We investigated the prognostic biomarker status of these ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e156c1c1ad14539dac924f2d08026a83
https://doi.org/10.21203/rs.3.rs-2370302/v1
https://doi.org/10.21203/rs.3.rs-2370302/v1
Autor:
Cumhur G. Ekmekçi, Neslihan Abaci, Sema Sirma Ekmekci, Burcu Salman, Melda Sariman, Zeliha Emrence, Çağrı Güleç
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 226-233 (2020)
Turkish Journal of Hematology
Turkish Journal of Hematology
Objective T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease resulting from the accumulation of genetic changes that affect the development of T-cells. The precise role of lymphoid enhancer-binding factor 1 (LEF1) in T-ALL has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2971123e1074cc64e977ecac14f5bc0
https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-33239&look4=
https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-33239&look4=
Autor:
Selami Günal, İsmail Özdemir, Engin Ulukaya, Melda Sariman, Mert Olgun Karataş, Namık Özdemir
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 50(33)
Herein, we report the synthesis, characterisation and preliminary biological evaluation of two novel silver(I) complexes of type [AgL2](NO3)3 (3 and 4) with ionic N-donor benzimidazoles. The complexes have been synthesized by the reaction of 1.5 equi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f50062755de26af3761cdc0f29094f18
https://pubmed.ncbi.nlm.nih.gov/34355725
https://pubmed.ncbi.nlm.nih.gov/34355725
Autor:
Mustafa Nuri Yenerel, Ferda Perçin Paçal, Duran Ustek, Sukru Ozturk, Sema Sirma Ekmekci, Sevgi Kalayoglu Besisik, Neslihan Abaci, Mesut Ayer, Aris Cakiris, Kivanc Cefle, Melda Sariman, Sukru Palanduz
Publikováno v:
Balkan Medical Journal, Vol 36, Iss 1, Pp 23-31 (2019)
Balkan Medical Journal
Balkan Medical Journal
Background Multiple myeloma is a plasma cell dyscrasia characterized by transformation of B cells into malignant cells. Although there are data regarding the molecular pathology of multiple myeloma, the molecular mechanisms of the disease have not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b97856ee49a31725b07eaae48c9c0bf
http://balkanmedicaljournal.org/text.php?lang=en&id=2032
http://balkanmedicaljournal.org/text.php?lang=en&id=2032
Autor:
Tatjana Stanojković, Merve Erkisa, Melda Sariman, Caner Geyik Geyik, Oyku Gonul Geyik, Engin Ulukay
Cancer is still a deadly disease, and its treatment desperately needs to be managed in a very sophisticated way through fast-developing novel strategies. Most of the cancer cases eventually develop into recurrencies, for which cancer stem cells (CSCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95424b34a27ec9b18e4b7cb68739904c
https://hdl.handle.net/20.500.12713/1922
https://hdl.handle.net/20.500.12713/1922
Autor:
Eylem, Taskin, Celal, Guven, Salih, Tunc Kaya, Melda, Sariman, Zeliha, Emrence, Sema Sirma, Ekmekci, Neslihan, Abaci, Yusuf, Sevgiler, Handan, Akcakaya
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(1)
Adriamycin (ADR) is a commonly used anti-cancer drug. ADR has toxic effects on cardiomyocytes and leads to heart failure. However, the underlying mechanism(s) by which ADR causes heart failure is still not clarified exactly. The aim of present study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28c8b6dba0684431b1e9ec728f138ef5
https://pubmed.ncbi.nlm.nih.gov/32277683
https://pubmed.ncbi.nlm.nih.gov/32277683
Autor:
Sema Sırma Ekmekci, Zeliha Emrence, Neslihan Abacı, Melda Sarıman, Burcu Salman, Cumhur Gökhan Ekmekci, Çağrı Güleç
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 226-233 (2020)
Objective: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease resulting from the accumulation of genetic changes that affect the development of T-cells. The precise role of lymphoid enhancerbinding factor 1 (LEF1) in T-ALL has been
Externí odkaz:
https://doaj.org/article/ab5f21f53d8345288e0d07ab581f2dbc
Autor:
Melda Sarıman, Neslihan Abacı, Sema Sırma Ekmekçi, Aris Çakiris, Ferda Perçin Paçal, Duran Üstek, Mesut Ayer, Mustafa Nuri Yenerel, Sevgi Beşışık, Kıvanç Çefle, Şükrü Palandüz, Şükrü Öztürk
Publikováno v:
Balkan Medical Journal, Vol 36, Iss 1, Pp 23-31 (2019)
Background: Multiple myeloma is a plasma cell dyscrasia characterized by transformation of B cells into malignant cells. Although there are data regarding the molecular pathology of multiple myeloma, the molecular mechanisms of the disease have not b
Externí odkaz:
https://doaj.org/article/6e465c95b66b417ab3cfbcd8bf7ca046